| Affiliation: | 1. Department of Medical Oncology, Center for Neuro-Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA;2. Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA;1. Immunology Program, Memorial Sloan Kettering Cancer Center, 408 East 69th Street, New York, NY 10021, USA;2. Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA;1. Laboratory of Hematology, Biology and Pathology Center, CHU of Lille, Lille, France;2. Department of Hematology, Hospital of the Miletrie, INSERM CIC 1402, CHU of Poitiers, Poitiers, France;3. INSERM UMR S 1172, Team 4, Cancer Research Institute, Lille, France;1. Department of Hematology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China;2. Center Laboratory, Affiliated Secondary Hospital, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China;3. Key Laboratory of Hematologic Malignancies, Diagnosis and Treatment, Zhejiang, Hangzhou, Zhejiang, China;4. Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, China;1. Department of Medicine, Section of Hematology & Oncology, University of Wisconsin School of Medicine and Public Health Madison, WI 53705-2275, USA;1. Division of Oncology, Department of Medicine, Stanford University, Stanford Cancer Institute, 875 Blake Wilbur Drive, Stanford, CA 94305, USA;2. Department of Medicine, NewYork-Presbyterian Hospital/Weill Cornell Medicine, 525 East 68th Street, New York, NY |
